Quidel Receives 510(k) Clearance of Its Sofia Fluorescent
Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions and cell-based virology assays, announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the sale of its Sofia Analyzer and its Sofia Influenza A+B FIA.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.